The groundbreaking treatment of the medication represents a major breakthrough in the care of the condition. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and the GIP hormone – resulting https://tirzepatidepeptide094734.bloguerosa.com/40642539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment